Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy

Vispo, Eugenia; Barreiro, Pablo; Plaza, Zulema; More

AIDS . 28(10):1473-1478, June 19, 2014.

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

Neukam, Karin; Caruz, Antonio; Rivero-Juárez, Antonio; More

AIDS . 27(17):2715-2724, November 13, 2013.

Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B

Plaza, Zulema; Aguilera, Antonio; Mena, Álvaro; More

AIDS . 27(14):2219-2224, September 10, 2013.

Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV–hepatitis C virus-coinfected patients with prior nonresponse or relapse

Labarga, Pablo; Barreiro, Pablo; Mira, José A; More

AIDS . 25(8):1131-1133, May 15, 2011.

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations

Rodríguez-Nóvoa, Sonia; Labarga, Pablo; D'Avolio, Antonio; More

AIDS . 24(7):1064-1066, April 24, 2010.

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

Labarga, Pablo; Barreiro, Pablo; Martin-Carbonero, Luz; More

AIDS . 23(6):689-696, March 27, 2009.

Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin

Rodríguez-Nóvoa, Sonia; Morello, Judit; González, Mar; More

AIDS . 22(18):2535-2537, November 30, 2008.

Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

de Mendoza, Carmen; Martin-Carbonero, Luz; Barreiro, Pablo; More

AIDS . 21(5):583-588, March 12, 2007.

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

Barrios, Ana; Rendón, Ana; Negredo, Eugenia; More

AIDS . 19(6):569-575, April 8, 2005.

Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

Pérez-Olmeda, Mayte; Núñez, Marina; Romero, Miriam; More

AIDS . 17(7):1023-1028, May 2, 2003.

Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir

Valer, Luisa; de Mendoza, Carmen; de Requena, Daniel González; More

AIDS . 16(14):1964-1966, September 27, 2002.

Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids

Barreiro, Pablo; Soriano, Vincent; Casas, Esperanza; More

AIDS . 14(14):2153-2157, September 29, 2000.